Citigroup’s CG Oncology CGON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$961K Sell
14,196
-3,493
-20% -$198K ﹤0.01% 3140
2025
Q4
$734K Sell
17,689
-18,682
-51% -$773K ﹤0.01% 3337
2025
Q3
$1.47M Sell
36,371
-13,758
-27% -$400K ﹤0.01% 2918
2025
Q2
$1.3M Sell
50,129
-45,753
-48% -$1.1M ﹤0.01% 3003
2025
Q1
$2.35M Buy
95,882
+24,246
+34% +$682K ﹤0.01% 2560
2024
Q4
$2.05M Buy
71,636
+36,430
+103% +$1.25M ﹤0.01% 2796
2024
Q3
$1.33M Buy
35,206
+24,597
+232% +$862K ﹤0.01% 3025
2024
Q2
$335K Buy
10,609
+6,325
+148% +$219K ﹤0.01% 3630
2024
Q1
$188K Buy
+4,284
New +$175K ﹤0.01% 4048

Other funds holding CGON